Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Organisation
Files
Mentors
Basic
Bibliography
Published theses
Top keywords
Keyword timeline
Co-mentors
Bibliography of the person, including all types of documents, not only theses.
MSc theses (1)
Maja Ljubič Pavalec:
Kognitivne motnje in druge klinične značilnosti alfasinukleinopatij pri preiskovancih z idiopatsko REM-motnjo spanja
Other documents (13)
Sara Redenšek Trampuž, Tanja Blagus, Maja Trošt, Vita Dolžan:
Serotonin-related functional genetic variants affect the occurrence of psychiatric and motor adverse events of dopaminergic treatment in Parkinson’s disease
Tomaž Rus, Jernej Mlakar, Luka Ležaič, An Vo, Nha Nguyen, Chris Chengke Tang, Michele Fiorini, Elena Prieto, Gloria Martí Andrés, Javier Arbizu, David Eidelberg, Maja Trošt:
Sporadic Creutzfeldt–Jakob disease is associated with reorganization of metabolic connectivity in a pathological brain network
Dejan Georgiev, Sentilija Delalić, Nina Zupančič-Križnar, Achinoam Socher, Tanya Gurevich, Maja Trošt:
Switching and combining device-aided therapies in advanced Parkinson’s disease
Sara Redenšek Trampuž, Barbara Jenko Bizjan, Maja Trošt, Vita Dolžan:
Clinical and clinical-pharmacogenetic models for prediction of the most common psychiatric complications due to dopamingeric treatment in Parkinson's disease
Sara Redenšek Trampuž, Dušan Flisar, Maja Kojović, Milica Gregorič Kramberger, Dejan Georgiev, Zvezdan Pirtošek, Maja Trošt, Vita Dolžan:
Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson's disease
Sara Redenšek Trampuž, Dušan Flisar, Maja Kojović, Milica Gregorič Kramberger, Dejan Georgiev, Zvezdan Pirtošek, Maja Trošt, Vita Dolžan:
Dopaminergic pathway genes influence adverse events related to dopaminergic treatment in Parkinson's disease
Tomaž Rus, Maša Premzl, Nina Zupančič-Križnar, Milica Gregorič Kramberger, Robert Rajnar, Lidija Ocepek, Zvezdan Pirtošek, Maja Trošt:
Adverse effects of levodopa/carbidopa intrajejunal gel treatment
Tina Levstek, Sara Redenšek Trampuž, Maja Trošt, Vita Dolžan, Katarina Trebušak Podkrajšek:
Assessment of the telomere length and its effect on the symptomatology of Parkinson's disease
Matej Perovnik, Petra Tomše, Jan Jamšek, Chris Chengke Tang, David Eidelberg, Maja Trošt:
Metabolic brain pattern in dementia with Lewy bodies
Sara Redenšek Trampuž, Tilen Kristanc, Tanja Blagus, Maja Trošt, Vita Dolžan:
Genetic variability of the vitamin D receptor affects susceptibility to Parkinson's disease and dopaminergic treatment adverse events
Boštjan Petrič, Sara Redenšek Trampuž, Vita Dolžan, Milica Gregorič Kramberger, Maja Trošt, Nikola Maraković, Marko Goličnik, Aljoša Bavec:
Investigation of paraoxonase-1 genotype and enzyme-kinetic parameters in the context of cognitive impairment in Parkinson’s disease
Katarina Vogelnik Žakelj, Maja Trošt, Petra Tomše, Igor N. Petrović, Aleksandra Tomić Pešić, Saša Radovanović, Maja Kojović:
Zolpidem improves task-specific dystonia
Tomaž Rus, Jernej Mlakar, Jan Jamšek, Maja Trošt:
Metabolic brain changes can predict the underlying pathology in neurodegenerative brain disorders